VenaBLOCK – Eravio Hospital

Advance Care Centre
For Glue Therapy By Vena Block

Advance Care Centre For Glue Therapy By Vena Block

What Are Glue Therapy By Vena Block?

The physician only needs USG guidance to perform the procedure in outpatient conditions within several minutes. VenaBLOCKⓇ brings advantages such as eliminating tumescent anesthesia, ease of use, shortening the procedure time, and prevention of complications such as burn marks, bruising, hematoma, numbness, and pigmentation in thermal ablation methods.

The VenaBLOCKⓇ closure system delivers immediate and lasting vein closure with its proprietary medical adhesive formula, with a demonstrated 94.6% closure rate at 3 years.

Meet Our Doctor

Dr. Maunil Ajay Bhuta

MBBS MD-Radio Diagnosis/Radiology DNB-Radio Diagnosis Interventional Radiologist, Radiologist

Maunil Bhuta is a well-reputed Neuro & Vascular Interventional Radiologist in Mumbai and has an experience of 9 years in his held. He completed MBBS Maharashtra University of Health Sciences, Nashik in 2012, MD Radio Diagnosis/Radiology from Maharashtra University of Health Sciences Nashik 2015 DNB-Radio Diagnosis from Lokmanya Tilak Municipal Medical College & General Hospital in 2016 and Fellowship in Endovascular Neuro Interventions FEND from Changhai Hospital from Shanghai in 2017

He is a gold medalist in the MD University examination. He has experience in performing clinical research in vascular and Interventional radiology as well as preparing manuscripts. Experienced at resident/undergraduate student teaching

wing years of experience in the heid he has earned the admiration of ten patients. He gives individual attention to every patient and is one of the most able doctors in Mumbal He is appreciated for handling complex neuro & vascular issues effortlessly He is caring dedicated and a friendly doctor who begi cunfidence in alt his patients, and staff He is skilled and has an excellent clinical and surgical approach to the patient condition

FEATURES

Can be performed in outpatient conditions.
Non-tumescent procedure. Short procedure time.
Closure of the target vessel can be obtained in seconds.
No burn marks, skin pigmentation or lesions, numbness.
No need to use compression stocking after the procedure.
Patients can return to daily routines and activities immediately.
VenaBLOCKⓇ MicroCatheter
Braided PTFE Catheter
Laser-guided
High echogenicity and better visibility under USG
Excellent pushability
Marked on every 2 cm

TECHNICAL SPECS

The VenaBLOCKⓇ closure system is indicated for use in the closure of saphenous veins (vena saphena Magna, valve saphenous Parva) or perforator veins in endovenous treatment of incompetent varicose veins. VenaBLOCKⓇis an n-BCA-polymer structure that was changed by adding a monomer synthesized by the producing company. It is ready for use, blue-colored, transparent liquid. Product show polymerization effect with embolization. When contacted with living tissue and in humid environments, it very fast becomes polymerized by forming a thin, flexible membrane with high tension resistance that ensures sticking firmly to the tissues. The subject matter membrane ensures a natural fit with the structure of the tissues, it is watertight and does not affect the structures of the blood and organic liquids. This formed membrane, since the polymerization of the product does not cause the occurrence of glassy components, can easily be perforated with the surgical needle after it is hardened. The polymerization time changes according to the type of tissue polymer contacted, characteristics of the liquid foundation, and the amount of the product used. When it is applied in the right conditions, VenaBLOCKⓇ starts polymerization after 1-2 seconds and finishes the polymerization process in about 5 seconds.

POTENTIAL ADVERSE EFFECTS

Below is a list of the potential adverse effects (e.g., complications) associated with the use of theVenaBLOCKⓇ system. The adverse events associated with the device are similar to those with traditional endovenous thermal ablation procedures.

Allergic reactions to cyanoacrylates, such as hives, asthma, hay fever, and anaphylactic shock
Arteriovenous fistula
Bleeding from the site of access
Deep vein thrombosis (DVT)
Edema in the treated leg
Embolization, including pulmonary embolism (PE)
Hematoma
Hyperpigmentation
Infection at the access site
Non-specific mild inflammation of the cutaneous and subcutaneous tissue
Pain
Paresthesia
Urticaria or ulceration may occur at the site of injection
Vascular rupture and perforation
Visible scarring